Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCelgene shells out for antisense drug.AuthorsRatner, MarkAbstractThe article focuses on launch of the GED-0301, antisense drug by Celgene for the treatment of Crohn's disease and gastrointestinal disorders.SubjectsANTISENSE drugs; CELGENE Corp.PublicationNature Biotechnology, 2014, Vol 32, Issue 7, p605ISSN1087-0156Publication typeArticleDOI10.1038/nbt0714-605b